{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:37:10Z","timestamp":1789025830325,"version":"build-2803163510"},"reference-count":69,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPD"],"published-print":{"date-parts":[[2021,8,2]]},"abstract":"<jats:p>Background: Parkinson\u2019s disease (PD) is a prevalent neurodegenerative disease that is pathologically described as a six-stage \u03b1-synucleinopathy. In stage 4, \u03b1-synuclein reaches the hippocampus, inducing cognitive deficits, from which it progresses to the isocortex, leading to dementia. Among hippocampal fields, cornu ammonis 2 is particularly affected by this \u03b1-synucleinopathy and critical for cognitive decline. Volumetric studies using magnetic resonance imaging have produced controversial results, with only some reporting volume loss, whereas stereological data obtained using nonspecific markers do not reveal volume changes, neural or glial loss. Proteomic analysis has not been carried out in the hippocampus of patients with PD. Objective: This study aims to explain hippocampal changes in patients with PD at the cellular and proteomic levels. Methods: \u03b1-Synuclein inclusions, volume and neural (NeuN), microglial (Iba-1) and astroglial (GFAP) populations were stereologically analyzed. SWATH-MS quantitative proteomic analysis was also conducted. Results: Area fraction fractionator probe revealed a higher area fraction \u03b1-synucleinopathy in cornu ammonis 2. No volume change, neurodegeneration, microgliosis or astrogliosis was detected. Proteomic analysis identified 1,634 proteins, of which 83 were particularly useful for defining differences among PD and non-PD groups. Among them, upregulated (PHYIP, CTND2, AHSA1 and SNTA1) and downregulated (TM163, REEP2 and CSKI1) proteins were related to synaptic structures in the diseased hippocampus. Conclusion: The distribution of \u03b1-synuclein in the hippocampus is not associated with volumetric, neural or glial changes. Proteomic analysis, however, reveals a series of changes in proteins associated with synaptic structures, suggesting that hippocampal changes occur at the synapse level during PD.<\/jats:p>","DOI":"10.3233\/jpd-202465","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T13:02:42Z","timestamp":1622811762000},"page":"1345-1365","source":"Crossref","is-referenced-by-count":50,"title":["The Human Hippocampus in Parkinson\u2019s Disease: An Integrative Stereological and Proteomic Study"],"prefix":"10.1177","volume":"11","author":[{"given":"Sandra","family":"Villar-Conde","sequence":"first","affiliation":[{"name":"Neuroplasticity and Neurodegeneration Laboratory, Ciudad Real Medical School, CRIB, University of Castilla-La Mancha, Ciudad Real, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Astillero-Lopez","sequence":"additional","affiliation":[{"name":"Neuroplasticity and Neurodegeneration Laboratory, Ciudad Real Medical School, CRIB, University of Castilla-La Mancha, Ciudad Real, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Gonzalez-Rodriguez","sequence":"additional","affiliation":[{"name":"Neuroplasticity and Neurodegeneration Laboratory, Ciudad Real Medical School, CRIB, University of Castilla-La Mancha, Ciudad Real, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Villanueva-Anguita","sequence":"additional","affiliation":[{"name":"Neuroplasticity and Neurodegeneration Laboratory, Ciudad Real Medical School, CRIB, University of Castilla-La Mancha, Ciudad Real, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Saiz-Sanchez","sequence":"additional","affiliation":[{"name":"Neuroplasticity and Neurodegeneration Laboratory, Ciudad Real Medical School, CRIB, University of Castilla-La Mancha, Ciudad Real, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alino","family":"Martinez-Marcos","sequence":"additional","affiliation":[{"name":"Neuroplasticity and Neurodegeneration Laboratory, Ciudad Real Medical School, CRIB, University of Castilla-La Mancha, Ciudad Real, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Flores-Cuadrado","sequence":"additional","affiliation":[{"name":"Neuroplasticity and Neurodegeneration Laboratory, Ciudad Real Medical School, CRIB, University of Castilla-La Mancha, Ciudad Real, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Ubeda-Ba\u00f1on","sequence":"additional","affiliation":[{"name":"Neuroplasticity and Neurodegeneration Laboratory, Ciudad Real Medical School, CRIB, University of Castilla-La Mancha, Ciudad Real, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JPD-202465_ref1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.3233\/JPD-202465_ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.3233\/JPD-202465_ref3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of Lewy pathology","volume":"9","author":"Goedert","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JPD-202465_ref4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41593-018-0238-6","article-title":"Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases","volume":"21","author":"Jucker","year":"2018","journal-title":"Nat Neurosci"},{"key":"10.3233\/JPD-202465_ref5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","article-title":"Protein transmission in neurodegenerative disease","volume":"16","author":"Peng","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JPD-202465_ref6","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1126\/science.1222951","article-title":"Cell biology. A unifying role for prions in neurodegenerative diseases","volume":"336","author":"Prusiner","year":"2012","journal-title":"Science"},{"key":"10.3233\/JPD-202465_ref7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JPD-202465_ref8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.21541","article-title":"A critical evaluation of the Braak staging scheme for Parkinson\u2019s disease","volume":"64","author":"Burke","year":"2008","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-202465_ref9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.21638","article-title":"Critical evaluation of the Braak staging scheme for Parkinson\u2019s disease","volume":"67","author":"Jellinger","year":"2010","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-202465_ref10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jns.2011.05.027","article-title":"Progress in defining the premotor phase of Parkinson\u2019s disease","volume":"310","author":"Tolosa","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.3233\/JPD-202465_ref11","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/mds.27802","article-title":"Update of the MDS research criteria for prodromal Parkinson\u2019s disease","volume":"34","author":"Heinzel","year":"2019","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-202465_ref12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/mds.27670","article-title":"Prodromal Parkinson\u2019s disease: The decade past, the decade to come","volume":"34","author":"Postuma","year":"2019","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-202465_ref13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/nan.12298","article-title":"Review: Sporadic Parkinson\u2019s disease: Development and distribution of alpha-synuclein pathology","volume":"42","author":"Del Tredici","year":"2016","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JPD-202465_ref14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cortex.2018.11.021","article-title":"Episodic recognition memory and the hippocampus in Parkinson\u2019s disease: A review","volume":"113","author":"Das","year":"2019","journal-title":"Cortex"},{"key":"10.3233\/JPD-202465_ref15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.neuro.27.070203.144130","article-title":"The medial temporal lobe","volume":"27","author":"Squire","year":"2004","journal-title":"Annu Rev Neurosci"},{"key":"10.3233\/JPD-202465_ref16","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1007\/s00330-019-06043-9","article-title":"Do multiple system atrophy and Parkinson\u2019s disease show distinct patterns of volumetric alterations across hippocampal subfields? An exploratory study","volume":"29","author":"Wang","year":"2019","journal-title":"Eur Radiol"},{"key":"10.3233\/JPD-202465_ref17","first-page":"113","article-title":"Studies on the structure of the cerebral cortex. II. Continuation of the study of the Ammonic system","volume":"46","author":"Lorente de N\u00f3","year":"1934","journal-title":"J Psychol Neurol"},{"key":"10.3233\/JPD-202465_ref18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0079-6123(07)63003-9","article-title":"The perforant path: Projections from the entorhinal cortex to the dentate gyrus","volume":"163","author":"Witter","year":"2007","journal-title":"Prog Brain Res"},{"key":"10.3233\/JPD-202465_ref19","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/mds.26586","article-title":"Hippocampal alpha-synuclein and interneurons in Parkinson\u2019s disease: Data from human and mouse models","volume":"31","author":"Flores-Cuadrado","year":"2016","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-202465_ref20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev-neuro-080719-100343","article-title":"CA2: A highly connected intrahippocampal relay","volume":"43","author":"Middleton","year":"2019","journal-title":"Annu Rev Neurosci"},{"key":"10.3233\/JPD-202465_ref21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/1073858418778747","article-title":"Ammon\u2019s horn 2 (CA2) of the hippocampus: A long-known region with a new potential role in neurodegeneration","volume":"25","author":"Pang","year":"2019","journal-title":"Neuroscientist"},{"key":"10.3233\/JPD-202465_ref22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrn.2015.22","article-title":"Rediscovering area CA2: Unique properties and functions","volume":"17","author":"Dudek","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JPD-202465_ref23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF00296742","article-title":"Immunoreactivity profile of hippocampal CA2\/3 neurites in diffuse Lewy body disease","volume":"87","author":"Dickson","year":"1994","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-202465_ref24","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1212\/WNL.45.9.1768","article-title":"Ubiquitin-positive CA2\/3 neurites in hippocampus coexist with cortical Lewy bodies","volume":"45","author":"Kim","year":"1995","journal-title":"Neurology"},{"key":"10.3233\/JPD-202465_ref25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00702-013-1084-z","article-title":"A quantitative study of alpha-synuclein pathology in fifteen cases of dementia associated with Parkinson disease","volume":"121","author":"Armstrong","year":"2014","journal-title":"J Neural Transm"},{"key":"10.3233\/JPD-202465_ref26","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/WNL.49.6.1570","article-title":"The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson\u2019s disease","volume":"49","author":"Churchyard","year":"1997","journal-title":"Neurology"},{"key":"10.3233\/JPD-202465_ref27","first-page":"141","article-title":"Limbic neuropathology in idiopathic Parkinson\u2019s disease with concomitant dementia","volume":"42","author":"Bertrand","year":"2004","journal-title":"Folia Neuropathol"},{"key":"10.3233\/JPD-202465_ref28","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/mds.10444","article-title":"Parkinson\u2019s disease is associated with hippocampal atrophy","volume":"18","author":"Camicioli","year":"2003","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-202465_ref29","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/mds.27106","article-title":"Subcortical shape analysis of progressive mild cognitive impairment in Parkinson\u2019s disease","volume":"32","author":"Chung","year":"2017","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-202465_ref30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/jnnp-2011-300828","article-title":"Grey matter atrophy in cognitively impaired Parkinson\u2019s disease","volume":"83","author":"Melzer","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-202465_ref31","doi-asserted-by":"crossref","first-page":"e85595","DOI":"10.1371\/journal.pone.0085595","article-title":"Grey matter changes in cognitively impaired Parkinson\u2019s disease patients","volume":"9","author":"Rektorova","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JPD-202465_ref32","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00702-018-1891-3","article-title":"Hippocampal subfield atrophy in patients with Parkinson\u2019s disease and psychosis","volume":"125","author":"Lenka","year":"2018","journal-title":"J Neural Transm"},{"key":"10.3233\/JPD-202465_ref33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nicl.2016.12.008","article-title":"Associations of hippocampal subfields in the progression of cognitive decline related to Parkinson\u2019s disease","volume":"14","author":"Foo","year":"2016","journal-title":"Neuroimage Clin"},{"key":"10.3233\/JPD-202465_ref34","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.neuroscience.2017.12.028","article-title":"Relationship between hippocampal subfields and category cued recall in AD and PDD: A multimodal MRI study","volume":"371","author":"Novellino","year":"2018","journal-title":"Neuroscience"},{"key":"10.3233\/JPD-202465_ref35","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/hipo.22131","article-title":"Regional vulnerability of hippocampal subfields and memory deficits in Parkinson\u2019s disease","volume":"23","author":"Pereira","year":"2013","journal-title":"Hippocampus"},{"key":"10.3233\/JPD-202465_ref36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fneur.2018.00455","article-title":"On cell loss and selective vulnerability of neuronal populations in Parkinson\u2019s disease","volume":"9","author":"Giguere","year":"2018","journal-title":"Front Neurol"},{"key":"10.3233\/JPD-202465_ref37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41531-020-00154-7","article-title":"Astrogliosis and sexually dimorphic neurodegeneration and microgliosis in the olfactory bulb in Parkinson\u2019s disease","volume":"7","author":"Flores-Cuadrado","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"key":"10.3233\/JPD-202465_ref38","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/hipo.20212","article-title":"Hippocampal neuron and glial cell numbers in Parkinson\u2019s disease\u2013a stereological study","volume":"16","author":"Joelving","year":"2006","journal-title":"Hippocampus"},{"key":"10.3233\/JPD-202465_ref39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ana.10071","article-title":"Selective hippocampal neuron loss in dementia with Lewy bodies","volume":"51","author":"Harding","year":"2002","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-202465_ref40","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s10571-019-00700-9","article-title":"Proteomics in human Parkinson\u2019s disease: Present scenario and future directions","volume":"39","author":"Dixit","year":"2019","journal-title":"Cell Mol Neurobiol"},{"key":"10.3233\/JPD-202465_ref41","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/jnen\/nlx054","article-title":"alpha-Synucleinopathy in the human amygdala in Parkinson disease: Differential vulnerability of somatostatin- and parvalbumin-expressing neurons","volume":"76","author":"Flores-Cuadrado","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JPD-202465_ref42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00401-010-0687-9","article-title":"alpha-Synucleinopathy in the human olfactory system in Parkinson\u2019s disease: Involvement of calcium-binding protein- and substance P-positive cells","volume":"119","author":"Ubeda-Banon","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-202465_ref43","unstructured":"Mai J , Majtanik M , Paxinos G (2015) Atlas of the Human Brain, Elsevier, New York."},{"key":"10.3233\/JPD-202465_ref44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.902960102","article-title":"Unbiased stereological estimation of the number of neurons in the human hippocampus","volume":"296","author":"West","year":"1990","journal-title":"J Comp Neurol"},{"key":"10.3233\/JPD-202465_ref45","doi-asserted-by":"crossref","unstructured":"Insausti R , Amaral DG (2003) Hippocampal formation. In The Human Nervous System, Paxinos G, Mai J, eds. Academic Press, pp. 871\u2013914.","DOI":"10.1016\/B978-012547626-3\/50024-7"},{"key":"10.3233\/JPD-202465_ref46","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.3390\/nu11122984","article-title":"SWATH differential abundance proteomics and cellular assays show in vitro anticancer activity of arachidonic acid- and docosahexaenoic acid-based monoacylglycerols in HT-29 colorectal cancer cells","volume":"11","author":"Gonzalez-Fernandez","year":"2019","journal-title":"Nutrients"},{"key":"10.3233\/JPD-202465_ref47","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kramer","year":"2014","journal-title":"Bioinformatics"},{"key":"10.3233\/JPD-202465_ref48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s004010100390","article-title":"Cortical Lewy body pathology in the diagnosis of dementia","volume":"102","author":"Harding","year":"2001","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-202465_ref49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s004010051064","article-title":"Neuritic degeneration in the hippocampus and amygdala in Parkinson\u2019s disease in relation to Alzheimer pathology","volume":"98","author":"Mattila","year":"1999","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-202465_ref50","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1523\/JNEUROSCI.3047-16.2016","article-title":"Hippocampal alpha-synuclein in dementia with Lewy bodies contributes to memory impairment and is consistent with spread of pathology","volume":"37","author":"Adamowicz","year":"2017","journal-title":"J Neurosci"},{"key":"10.3233\/JPD-202465_ref51","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/cne.23263","article-title":"Hypothalamic and other connections with dorsal CA2 area of the mouse hippocampus","volume":"521","author":"Cui","year":"2013","journal-title":"J Comp Neurol"},{"key":"10.3233\/JPD-202465_ref52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-020-00200-7","article-title":"The human olfactory system in two proteinopathies: Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"9","author":"Ubeda-Banon","year":"2020","journal-title":"Transl Neurodegener"},{"key":"10.3233\/JPD-202465_ref53","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2017.10.017","article-title":"Critical appraisal of pathology transmission in the alpha-synuclein fibril model of Lewy body disorders","volume":"299","author":"Nouraei","year":"2018","journal-title":"Exp Neurol"},{"key":"10.3233\/JPD-202465_ref54","doi-asserted-by":"crossref","first-page":"14080","DOI":"10.1073\/pnas.0904775106","article-title":"Regional differences in hippocampal calcium handling provide a cellular mechanism for limiting plasticity","volume":"106","author":"Simons","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-202465_ref55","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3389\/fneur.2020.00595","article-title":"Biofluid markers for prodromal Parkinson\u2019s disease: Evidence from a catecholaminergic perspective","volume":"11","author":"Vermeiren","year":"2020","journal-title":"Front Neurol"},{"key":"10.3233\/JPD-202465_ref56","doi-asserted-by":"crossref","first-page":"12804","DOI":"10.1038\/s41598-020-69480-3","article-title":"A glycomics and proteomics study of aging and Parkinson\u2019s disease in human brain","volume":"10","author":"Raghunathan","year":"2020","journal-title":"Sci Rep"},{"key":"10.3233\/JPD-202465_ref57","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia","volume":"120","author":"Schulz-Schaeffer","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-202465_ref58","doi-asserted-by":"crossref","first-page":"16843","DOI":"10.1038\/s41598-019-53317-9","article-title":"Dendritic spine morphology and memory formation depend on postsynaptic Caskin proteins","volume":"9","author":"Bencsik","year":"2019","journal-title":"Sci Rep"},{"key":"10.3233\/JPD-202465_ref59","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.tcb.2005.01.004","article-title":"Delta-catenin at the synaptic-adherens junction","volume":"15","author":"Kosik","year":"2005","journal-title":"Trends Cell Biol"},{"key":"10.3233\/JPD-202465_ref60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2019.04.006","article-title":"Improved memory and reduced anxiety in delta-catenin transgenic mice","volume":"318","author":"Ryu","year":"2019","journal-title":"Exp Neurol"},{"key":"10.3233\/JPD-202465_ref61","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.2741\/4546","article-title":"The mucolipin-1 (TRPML1) ion channel, transmembrane-163 (TMEM163) protein, and lysosomal zinc handling","volume":"22","author":"Cuajungco","year":"2017","journal-title":"Front Biosci"},{"key":"10.3233\/JPD-202465_ref62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pnpbp.2012.03.011","article-title":"Psychotropic drug effects on gene transcriptomics relevant to Parkinson\u2019s disease","volume":"38","author":"Lauterbach","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.3233\/JPD-202465_ref63","doi-asserted-by":"crossref","first-page":"9707","DOI":"10.1073\/pnas.1707039114","article-title":"Hsp90 activator Aha1 drives production of pathological tau aggregates","volume":"114","author":"Shelton","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-202465_ref64","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s41422-018-0065-z","article-title":"DNA damage triggers tubular endoplasmic reticulum extension to promote apoptosis by facilitating ER-mitochondria signaling","volume":"28","author":"Zheng","year":"2018","journal-title":"Cell Res"},{"key":"10.3233\/JPD-202465_ref65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/nyas.14212","article-title":"Endoplasmic reticulum-mitochondria crosstalk: From junction to function across neurological disorders","volume":"1457","author":"Veeresh","year":"2019","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JPD-202465_ref66","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/jcbfm.2011.120","article-title":"Proteomic analysis of mitochondria in APOE transgenic mice and in response to an ischemic challenge","volume":"32","author":"James","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JPD-202465_ref67","doi-asserted-by":"crossref","first-page":"13615","DOI":"10.1073\/pnas.2336064100","article-title":"Delayed K+clearance associated with aquaporin-4 mislocalization: Phenotypic defects in brains of alpha-syntrophin-null mice","volume":"100","author":"Amiry-Moghaddam","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JPD-202465_ref68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neuroscience.2005.08.051","article-title":"Differential effect of alpha-syntrophin knockout on aquaporin-4 and Kir4.1 expression in retinal macroglial cells in mice","volume":"137","author":"Puwarawuttipanit","year":"2006","journal-title":"Neuroscience"},{"key":"10.3233\/JPD-202465_ref69","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.brainresbull.2017.02.011","article-title":"The role of aquaporin-4 in synaptic plasticity, memory and disease","volume":"136","author":"Hubbard","year":"2018","journal-title":"Brain Res Bull"}],"container-title":["Journal of Parkinson's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JPD-202465","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:49:32Z","timestamp":1777610972000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JPD-202465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,2]]},"references-count":69,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jpd-202465","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,2]]}}}